Sagga, Lailyn D.
HRN: 19-74-64 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/04/2024
09/11/2024
IV
500
Q8
Acute Appendicitis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes